Otolaryngologic manifestations of small vessel vasculitis

Auris Nasus Larynx

Volumn 29, Issue 4, 2002, Pages 353-356

  Metaxaris, George ^a   Prokopakis, Emmanuel P ^b   Karatzanis, Alexander D ^b   Sakelaris, George ^a   Heras, Panagiotis ^a   Velegrakis, George A ^b   Helidonis, Emmanuel S ^b  

^a Kos General Hospital   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

ENT manifestations; Small vessel vasculitis; Wegener's granulomatosis

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENT EXAMINATION; EPISTAXIS; FEMALE; HEMOPTYSIS; HUMAN; MALE; NECROTIZING ARTERITIS; OTORHINOLARYNGOLOGY; PATIENT CODING; RETROSPECTIVE STUDY; SEROUS OTITIS MEDIA; SINUSITIS; SMALL VESSEL VASCULITIS; SORE THROAT; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHURG-STRAUSS SYNDROME; FEVER; HUMANS; NASAL OBSTRUCTION; POLYARTERITIS NODOSA; RETROSPECTIVE STUDIES; SINUSITIS; WEGENER GRANULOMATOSIS;

EID: 0036775286     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-8146(02)00062-7     Document Type: Article

References (23)

1. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., Hagen E.C., Hoffman G.S., Hunder G.G., Kallenberg C.G., et al. Nomenclature of systemic vasculitides; proposal of an international consensus conference. Arthritis Rheum. 37:1994;187-192.
2. Alarcon-Segovia D. Classification of the necrotising vasculitides in man. Clin. Rheum. Dis. 6:1980;223-231.
3. Lhote F., Guillevin L. Polyarteritis nodosa, microscopic polyangitis and Churg-Strauss syndrome: clinical aspects and treatment. Rheum. Dis. Clin. North Am. 21:1995;911-947.
4. Hunder G.G., Arend W.P., Bloch D.A., Calabrese L.H., Fauci A.S., Fries J.F., Leavitt R.Y., Lie J.T., Lightfoot R.W. Jr, Masi A.T., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: introduction. Arthritis Rheum. 33:1990;1065-1067.
5. Savage C.O., Harper L., Adu D. Primary systemic vasculitis. Lancet. 349:1997;553-558.
6. Gross W.L., Schmidt W.H., Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin. Exp. Immunol. 91:1993;1-12.
7. Kallenberg C.G., Brouwer E., Weening J.J., Tervaert J.W. Antineutrophil cytoplasmic antibodies: current diagnostic and pathophysiologic potential. Kidney Int. 46:1994;1-15.
8. Jennette J.C., Falk R.J. Antineutrophil cytoplasmic antibodies: discovery, specificity, disease associations and pathogenic potential. Adv. Pathol. Lab. Med. 8:1995;363-378.
9. Guillevin L., Lhote F., Amouroux J., Gherardi R., Callard P., Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group. Br. J. Rheumatol. 35:1996;958-964.
10. Dolman K.M., Gans R.O., Vervaat T.J., Zevenbergen G., Maingay D., Nikkels R.E., Donker A.J., von dem Borne A.E., Goldschmeding R. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propythiouracil therapy. Lancet. 342:1993;651-652.
11. Fauci A.S., Haynes B.F., Katz P., Wolff S.M. Wegener's Granulomatosis: prospective clinical and therapeutic experience with 85 patients for 25 years. Ann. Intern. Med. 98:1983;76-85.
12. Bacon P.A. Therapy of vasculitis. J. Rheumatol. 21:1994;788-790.
13. Sneller M.C., Hoffman G.S., Talar-Williams C., Kerr G.S., Hallahan C.W., Fauci A.S. An analysis of forty-two Wegener's Granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum. 38:1995;608-613.
14. Adu D., Pall A., Luqmani R.A., Richards N.T., Howie A.J., Emery P., Michael J., Savage C.O., Bacon P.A. Controlled trial of pulsed versus continuous predisolone and cyclophosphamide in the treatment of systemic vasculitis. Q. J. Med. 90:1997;401-409.
15. Gaughan R.K., DeSanto L.W., McDonald T.J. Use of anticytoplasmic autoantibodies in the diagnosis of Wegener's Granulomatosis with subglottic stenosis. Laryngoscope. 100:1990;561-563.
16. Jones N.S. Nasal manifestations of rheumatic diseases. Ann. Rheum. Dis. 58:1999;589-590.
17. Hirose K., Wener M.H., Duckert L.G. Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope. 109:(11):1999;1749-1754.
18. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., Arend W.P., Calabrese L.H., Fries J.F., Lie J.T., Lightfoot R.W. Jr, et al. The American College of Rheumatology criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 33:1990;1101-1107.
19. Masi A.T., Hunder G.G., Lie J.T., Michel B.A., Bloch D.A., Arend W.P., Calabrese L.H., Edworthy S.M., Fauci A.S., Leavitt R.Y., et al. The American College of Rheumatology criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 33:1990;1094-1100.
20. Boki K.A., Panayi G.S., Vaughan R.W., Drosos A.A., Moutsopoulos H.M., Lanchbury J.S. HLA- class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greece. The HLA-DRb shared-epitoped hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum. 35:(7):1992;749-755.
21. Reveille J.D., Amett F.C., Olsen M.L., Moulds J.M. Papasteriades CA, Moutsopoulos HM: HLA- class II alleles and C4 null genes in Greeks with systemic lupus erythematosus. Tissue Antigens. 46:1995;417-421.
22. Jennette J.C., Falk R.J. Small vessel vasculitis. New Engl. J. Med. 337:(21):1997;1512-1523.
23. O'Devaney K., Ferlito A., Hunter B.C., Devaney S.L., Rinaldo A. Wegener's granulomatosis of the head and neck. Ann. Otol. Rhinol. Laryngol. 107:1998;439-444.